We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medtronic PLC | NYSE:MDT | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.72 | 33 | 12:31:29 |
SAN DIEGO, June 27, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of HeartWare International, Inc. (NASDAQ: HTWR) breached their fiduciary duties in connection with the proposed sale of the Company to Medtronic plc (NYSE: MDT).
Additional Information:
HeartWare designs, develops, manufactures and markets miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure.
On June 27, 2016, HeartWare announced it had signed a definitive merger agreement with Medtronic. Under the terms of the agreement, HeartWare stockholders will receive $58.00 per share in cash. The proposed transaction is subject to regulatory approval.
The investigation concerns whether the HeartWare board failed to satisfy their duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for HeartWare shares of common stock. Nationally recognized Johnson & Weaver is investigating whether the proposed deal price represents adequate consideration; especially given that the price target for one Wall Street analyst is $60.00. The 52-week high for HeartWare stock is $94.15.
If you are a shareholder of HeartWare and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (jimb@johnsonandweaver.com) at 619-814-4471. If emailing, please include a phone number where you can be reached.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Contact:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com
Logo - http://photos.prnewswire.com/prnh/20160211/332409LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/heartware-htwr-alert-johnson--weaver-llp-launches-an-investigation-into-the-fairness-of-price-and-process-in-proposed-sale-of-heartware-international-inc-are-shareholders-getting-a-fair-price-300290447.html
SOURCE Johnson & Weaver, LLP
Copyright 2016 PR Newswire
1 Year Medtronic Chart |
1 Month Medtronic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions